Latest & greatest articles for corticosteroids

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on corticosteroids or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on corticosteroids and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for corticosteroids

141. Corticosteroid-eluting bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis

Corticosteroid-eluting bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis Corticosteroid-eluting bioabsorbable stent or Corticosteroid-eluting bioabsorbable stent or spacer insertion during endoscopic sinus surgery spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis to treat chronic rhinosinusitis Interventional procedures guidance Published: 23 March 2016 nice.org.uk/guidance/ipg551 Y Y our responsibility our (...) of implementing NICE recommendations wherever possible. 1 1 Recommendations Recommendations 1.1 Current evidence on the safety of corticosteroid-eluting bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis raises no major safety concerns. The evidence on efficacy is limited; there is © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 1 of 7some evidence of improving sinus

2016 National Institute for Health and Clinical Excellence - Interventional Procedures

142. Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment Full Text available with Trip Pro

Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment The diagnostic diversity of polymyalgia rheumatica (PMR) can easily be obscured by the widespread use of corticosteroids (CSs) early in the disease course. This study observed the course of PMR without CSs and determined whether alternative medication could be useful.Seventy patients with new-onset PMR comprised phase 1. Eight were removed with specific diagnoses (four with giant cell arteritis [GCA

2016 Open access rheumatology : research and reviews

143. Antenatal corticosteroid treatment for lung maturation

Fields] AND ("adrenal cortex hormones"[MeSH Terms] OR ("adrenal"[All Fields] AND "cortex"[All Fields] AND "hormones"[All Fields]) OR "adrenal cortex hormones"[All Fields] OR "corticosteroids"[All Fields]) ** ("caesarean section"[All Fields] OR "cesarean section"[MeSH Terms] OR ("cesarean"[All Fields] AND "section"[All Fields]) OR "cesarean section"[All Fields]) AND antenatal[All Fields] AND ("betamethasone"[MeSH Terms] OR "betamethasone"[All Fields]) Celeston Sandbjerg 2016 12 Appendikser Appendiks 1 (...) for de umiddelbare kortsigtede respiratoriske komplikationer vurderes at veje væsentligt tungere end de potentielle uafklarede kognitive langtidsbivirkninger. Kliniske rekommandationer Styrke Ved elektivt sectio efter uge 34+0 kan celeston ikke generelt anbefales. ê? Celeston Sandbjerg 2016 11 Litteratur søgningsmetode Rescue: Litteratursøgning afsluttet dato: oktober 2015 Databaser der er søgt i: Pubmed og Cochrane Library Søgetermer: Rescue doses, repeat doses, Adrenal Cortex Hormones, repeat

2016 Nordic Federation of Societies of Obstetrics and Gynecology

144. Implementation of the Use of Antenatal Corticosteroids in the Late Preterm Birth Period in Women at Risk for Preterm Delivery Full Text available with Trip Pro

Implementation of the Use of Antenatal Corticosteroids in the Late Preterm Birth Period in Women at Risk for Preterm Delivery Implementationoftheuseofantenatal corticosteroidsinthelate pretermbirthperiod inwomenatriskforpretermdelivery Society for Maternal-Fetal Medicine (SMFM) Publications Committee The practice of medicine continues to evolve, and individual circumstances will vary. This publication re?ects information (...) of antenatal corticosteroids prior to 34 weeks of gestation is standard practice for women at highriskfordeliveryinthenext7days, 3 suchtreatmenthas not been recommended for women during late preterm period birth because of the lack of supportive data from randomized controlled trials. Thepurposeofthisdocumentistoreviewthe?ndingsofa recentlyconductedrandomizedcontrolledtrialevalatingthe use of antental corticosteroids in late preterm pregnancies and to provide guidance for implementation into clinical

2016 Society for Maternal-Fetal Medicine

145. British Pain Society/Faculty of Pain Medicine (RCA) Consensus Statement on the use of Corticosteroids for Neuraxial Procedures in the UK

British Pain Society/Faculty of Pain Medicine (RCA) Consensus Statement on the use of Corticosteroids for Neuraxial Procedures in the UK British Pain Society/Faculty of Pain Medicine (RCA) Consensus Statement on the use of Corticosteroids for Neuraxial Procedures in the UK. There has been international debate relating to the use of corticosteroids for neuraxial interventions. This has included the publication of conflicting statements which will add to the challenges faced by the pain physician (...) use of corticosteroids in epidural injections for the acute relief of symptoms, particularly in the presence of acute radicular pain with disc herniation. 6? There is only limited evidence that particulate corticosteroid preparations have better efficacy than non-particulate preparations in the short term. There is no long term data to indicate efficacy of any steroid preparation. ? Some preservative formulations used in steroid preparations may be neurotoxic. Based on current evolving evidence

2016 Faculty of Pain Medicine

146. Short-term Improvements in Disability Mediate Patient Satisfaction After Epidural Corticosteroid Injections for Symptomatic Lumbar Spinal Stenosis (Abstract)

Short-term Improvements in Disability Mediate Patient Satisfaction After Epidural Corticosteroid Injections for Symptomatic Lumbar Spinal Stenosis Secondary analysis of data from a double-blind randomized controlled trial.To identify mediators of the effect of lumbar epidural injections of corticosteroid plus lidocaine on patient satisfaction at 6 weeks postinjection in patients with lumbar spinal stenosis. We hypothesized that short-term (≤3 wk) change in leg pain would be a significant (...) mediator of satisfaction.No prior studies have identified mediators of effects of epidural injections on patient satisfaction with treatment of lumbar spinal stenosis.We used mediation analysis methods to examine selected intermediate variables (adverse events and change in leg pain, back pain, disability, depression, and fatigue at 3 wk) as potential mediators of the effect of lumbar epidural injections of corticosteroid plus lidocaine on patient satisfaction with treatment. We used the overall

2016 EvidenceUpdates

147. Prescribing for rheumatological conditions in pregnancy and breastfeeding - Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Full Text available with Trip Pro

Prescribing for rheumatological conditions in pregnancy and breastfeeding - Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs (...) and corticosteroids | Rheumatology | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation September 2016 Article Contents Article Navigation BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids Julia Flint 1 Centre for Rheumatology Research, UCL Division of Medicine

2016 British Society for Rheumatology

148. Corticosteroid treatment of duchenne muscular dystrophy

Corticosteroid treatment of duchenne muscular dystrophy Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share February 02, 2016 ; 86 (5) Special Article Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy Report of the Guideline Development (...) .), Loma Linda University Medical Center, CA; and Departments of Pediatric and Neurology/Neurosurgery (M.O.), McGill University, Montréal, Canada. Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy David Gloss , Richard T. Moxley , Stephen Ashwal , Maryam Oskoui Neurology Feb 2016, 86 (5) 465-472; DOI: 10.1212/WNL.0000000000002337 Citation Manager Formats Make Comment See Comments Downloads 5504 Share Abstract Objective: To update the 2005 American Academy

2016 American Academy of Neurology

149. Do Systemic Corticosteroids Improve Outcomes in Chronic Obstructive Pulmonary Disease Exacerbations?

Do Systemic Corticosteroids Improve Outcomes in Chronic Obstructive Pulmonary Disease Exacerbations? Systematic Review Snapshot TAKE-HOME MESSAGE Systemic corticosteroid treatment (oral or parenteral) in the setting of chronic obstructive pulmonary disease exacerbations is effective in reducing the likelihood oftreatmentfailureandrelapseat1monthwhileshorteninghospitallengthofstay. Do Systemic Corticosteroids Improve OutcomesinChronic ObstructivePulmonary Disease Exacerbations? EBEM Commentators (...) Jeremy M. Hernandez, MD, PhD Division of Emergency Medicine McMaster University Hamilton, Ontario, Canada Marcia Edmonds, MD, MSc Division of Emergency Medicine Western University London, Ontario, Canada Results Sixteen studies with 1,787 partici- pants comparing corticosteroid with placebo (mostly inpatients) and 4 studies with 298 inpatients comparing parenteral corticoste- roid and oral corticosteroid were included. The mean age of study participants was 68 years. The me- dian proportion of men

2016 Annals of Emergency Medicine Systematic Review Snapshots

150. Do Corticosteroids Provide Benefit to Patients With Community-Acquired Pneumonia?

Do Corticosteroids Provide Benefit to Patients With Community-Acquired Pneumonia? TAKE-HOME MESSAGE For adult patients with community-acquired pneumonia requiring hospitalization, datasuggestthatcorticosteroid therapy mayreduce mortality, needformechanical ventilation, and hospital length of stay. Do Corticosteroids Provide Bene?t to Patients With Community-Acquired Pneumonia? EBEM Commentators Michael Gottlieb, MD John Bailitz, MD Department of Emergency Medicine Cook County Hospital Chicago (...) as an intravenous bolus followed by an infusion for 7 to 10 days. Five studies enrolling 70% of the total sample had an overall low risk of bias. Of the remaining studies, 6 had incom- plete allocation concealment, 4 had inadequate blinding, 1 had incomplete follow-up, and 1 was halted early after statistical signi- ?cance was attained during a planned interim analysis. Overall, systemic corticosteroids demonstrated decreased need for mechanical ventilation, decreased progression to acute respiratory distress

2016 Annals of Emergency Medicine Systematic Review Snapshots

151. Randomized controlled trial: Ultrasound-guided corticosteroid injections for adhesive capsulitis more effective than placebo

Randomized controlled trial: Ultrasound-guided corticosteroid injections for adhesive capsulitis more effective than placebo Ultrasound-guided corticosteroid injections for adhesive capsulitis more effective than placebo | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Ultrasound-guided corticosteroid injections for adhesive capsulitis more effective than placebo Article Text Therapeutics/Prevention Randomized controlled trial

2016 Evidence-Based Medicine

152. Systematic review: Best evidence supports topical corticosteroids and routine saline irrigations for medical treatment of chronic rhinosinusitis

Systematic review: Best evidence supports topical corticosteroids and routine saline irrigations for medical treatment of chronic rhinosinusitis Best evidence supports topical corticosteroids and routine saline irrigations for medical treatment of chronic rhinosinusitis | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies (...) , please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Best evidence supports topical corticosteroids and routine saline irrigations for medical treatment of chronic

2016 Evidence-Based Medicine

153. Systematic review with meta analysis: Adjunctive corticosteroids improve the need for mechanical ventilation and shorten hospital duration in patients hospitalised with community-acquired pneumonia

Systematic review with meta analysis: Adjunctive corticosteroids improve the need for mechanical ventilation and shorten hospital duration in patients hospitalised with community-acquired pneumonia Adjunctive corticosteroids improve the need for mechanical ventilation and shorten hospital duration in patients hospitalised with community-acquired pneumonia | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your (...) cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Adjunctive corticosteroids

2016 Evidence-Based Medicine

154. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations Full Text available with Trip Pro

Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations Short-term targeted treatment can potentially prevent fall asthma exacerbations while limiting therapy exposure.We sought to compare (1) omalizumab with placebo and (2) omalizumab with an inhaled corticosteroid (ICS) boost with regard to fall exacerbation rates when initiated 4 to 6 weeks before return to school.A 3-arm, randomized, double-blind, double placebo-controlled

2015 EvidenceUpdates Controlled trial quality: predicted high

155. Adjuvant corticosteroids for reducing death in neonatal bacterial meningitis. (Abstract)

Adjuvant corticosteroids for reducing death in neonatal bacterial meningitis. Bacterial meningitis remains a significant cause of neonatal and childhood morbidity and mortality in many countries of the world, particularly in developing countries. In some instances, children recover but remain impaired as a result of neurological sequelae such as hearing loss, developmental delay and cognitive impairment.To assess the effectiveness and safety of adjunctive corticosteroids in reducing death (...) and neurological sequelae in neonates with bacterial meningitis.We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2015, Issue 7), MEDLINE via PubMed (1966 to July 2015), African Index Medicus (up to January 2015), the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (up to July 2015), EMBASE (up to July 2015) and the metaRegister of Controlled Trials (mRCT) for ongoing trials.All randomised controlled trials (RCTs) or quasi-RCTs of adjunctive corticosteroids

2015 Cochrane

156. Effects of corticosteroids on hyposmia in persistent allergic rhinitis. (Abstract)

Effects of corticosteroids on hyposmia in persistent allergic rhinitis. To asses the effects of two topical nasal corticosteroids sprays on hyposmia in patients with persistent allergic rhinitis.The study was a prospective clinical trial and it included twenty four patients with persistent allergic rhinitis (PER) and hyposmia (H). The patients were divided into two groups depending on the type of corticosteroid topical nasal spray treatment: group A, 200 micrograms dose of mometasone furoate (...) (MF) and group B, 110 micrograms dose of fluticasone furoate (FF) both administered in the morning for 4 weeks. The olfactory function of the patients was evaluated with the extended Test battery "Sniffin' Sticks". The visual analogue scale (VAS) was used for the assessment of hyposmia, nasal discharge. The level of the nasal obstruction, before and after the treatment, was evaluated through the anterior rhinomanometry.The comparisons between the two types of topical corticosteroids showed

2015 Clujul medical (1957) Controlled trial quality: uncertain

157. Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial. Full Text available with Trip Pro

Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial. The efficacy and safety of long-acting β-agonists (LABAs) have been questioned. Black populations may be disproportionately affected by LABA risks.To compare the effectiveness and safety of tiotropium vs LABAs, when used with inhaled corticosteroids (ICS) in black adults with asthma and to determine whether allelic variation at the Arg16Gly locus (...) ,) and were followed up for up to 18 months. Patients underwent genotyping, attended study visits at baseline, 1, 6, 12, and 18 months, and completed monthly questionnaires.The primary outcome was time to asthma exacerbation, defined as a worsening asthma event requiring oral or parenteral corticosteroids. Secondary outcomes included patient-reported outcomes (Asthma Quality of Life Questionnaire, Asthma Control Questionnaire [ACQ], Asthma Symptom Utility Index, and Asthma Symptom-Free Days questionnaire

2015 JAMA Controlled trial quality: predicted high

158. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma. Full Text available with Trip Pro

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma. Long-acting muscarinic antagonists (LAMA), a class of drugs with proven effectiveness in chronic obstructive pulmonary disease (COPD), are being considered as an add-on option for adults with asthma whose condition is uncontrolled on inhaled corticosteroids (ICS). It is important to assess the safety and efficacy of LAMA add-on as an alternative to the prolonged use (...) duplicate screening, data extraction and risk of bias judgements, and to form a consensus where discrepancies arose. We used standard methods expected by The Cochrane Collaboration.The pre-specified primary outcomes were exacerbations requiring a course of oral corticosteroids (OCS), effects on quality of life and serious adverse events.One cross-over randomised controlled trial met the inclusion criteria. The trial was performed in 210 patients with moderate to severe asthma and compared the use

2015 Cochrane

159. Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. (Abstract)

, quality of life and adverse effects of steroids.A single RCT was included that recruited five children in a double blind cross-over trial. One child was withdrawn prematurely from the study and another had infantile spasms and hence was excluded from further analysis. Adrenocorticotrophin hormone (ACTH 4-9) was administered. Of the three children analysed, one showed a reduction in seizures of 25% to 50% at both the low and higher doses of corticosteroids compared to placebo; one child showed (...) Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. This is an updated version of the original Cochrane review published in Issue 1, 2007.Epilepsy is a disorder with recurrent epileptic seizures. Corticosteroids have been used in the treatment of children with epilepsy and have significant adverse effects. Their efficacy and tolerability have not been clearly established.To determine the efficacy, in terms of seizure control, improvements in cognition

2015 Cochrane

160. Epicondylitis (tennis elbow) and corticosteroids: less success than physiotherapy

Epicondylitis (tennis elbow) and corticosteroids: less success than physiotherapy Prescrire IN ENGLISH - Spotlight ''Epicondylitis (tennis elbow) and corticosteroids: less success than physiotherapy'', 1 June 2015 {1} {1} {1} | | > > > Epicondylitis (tennis elbow) and corticosteroids: less success than physiotherapy Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |    (...) |  Spotlight Epicondylitis (tennis elbow) and corticosteroids: less success than physiotherapy A local corticosteroid injection gives short-term relief, but increases the risk of recurrence, in contrast to physiotherapy. Patients suffering from epicondylitis, or "tennis elbow", generally experience pain around the outside of the elbow. The pain is generally moderate and is triggered by certain movements, but it can become intense and continual, restricting activity and reducing grip strength

2015 Prescrire